Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Good afternoon, and thank you for joining today's conference call to discuss Peraso Fourth Quarter and Full Year 2025 financial ...

AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but ...

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...

Earnings call CAREL Industries reported FY 2025 revenue of EUR 629 million, up 8.7% YoY (10.6% organic), with Q4 organic growth accelerating to 16.9%. Adjusted EBITDA margin reached 20%, and net ...

Samsung Galaxy S26 Ultra and Buds 4 Pro engineering brief : f/1.4 aperture, AI-ISP selfie, APV 8K codec, Super Wide Woofer, ...

Detailed price information for Alphatec Holdings (ATEC-Q) from The Globe and Mail including charting and trades.